Expression of Somatostatin Receptors in Phaeochromocytoma and Paragangliomas

Nassim Parvizi, Tricia Tan(Imperial College London), Radha Ramachandran(Hammersmith Hospital), Karim Meeran(Imperial College London), Marco Vergine(Hammersmith Hospital), Ali Alsafi(Imperial College Healthcare NHS Trust), Fausto Palazzo(Hammersmith Hospital), Roberto Dina(Imperial College London), David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Niamh Martin(Hammersmith Hospital), Rohini Sharma(Hammersmith Hospital)
Society for Endocrinology BES 2012
March 1, 2012
10.1037/a0015757
Cited by 2

Related Papers

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
|JAMA Oncology|2019|582
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
|JAMA|2018|406
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
|Surgery|2011|266
Association between high serum total cortisol concentrations and mortality from COVID-19
|The Lancet Diabetes & Endocrinology|2020|260
Thyroid Function Before, During, and After COVID-19
|The Journal of Clinical Endocrinology & Metabolism|2020|220